Skip to main content

Kp Tissue Inc(KPT-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Kp Tissue Inc down on Thursday (KPT)

Automated Summaries - The Globe and Mail - Thu May 2, 4:01PM CDT

Today during trading, Kp Tissue Inc stock opened at $8.25 and closed at $8.20. prices ranged from $8.19 to $8.25.

Share prices decreased -0.73 percent from the previous day's close of $8.26.

Today across North America, the TSX Composite closed 0.06% at 21728.55, the S&P 500 closed -0.34% at 5018.39, the Dow Jones Industrial Average closed 0.23% at 37903.29 and the Nasdaq Composite closed -0.33% at 15605.48.

Kp Tissue Inc has listed on the Toronto Stock Exchange (TSX) under the ticker KPT.

A total of 8,300 shares was traded during the last trading day, with total trades of 23, while having an average volume of 9,440 over the last 5-days.

Trading across the entire TSX saw 3,697 price advancers against 1,526 declines and 95 unchanged.

During the prior 52 weeks, KPT.TO has traded as high as $10.84 (July 26,2023) and low as $8.18 (May 01,2024). Moreover, in the last 52 weeks, Kp Tissue Inc's shares have dipped -19.29 percent, while they have decreased -9.09% since the start of 2024.

It announced a 0.18 dividend on March 07/24, with an March 28/24 ex-date and April 15/24 pay day.

Following today's trading, Kp Tissue Inc has a market capitalization of $82.30 million on a float of 9,964 shares outstanding. Its annual EPS is $-0.50.

Kp Tissue Inc is a TSX Household & Personal Product company headquartered in Mississauga, CAN.

Currently, Kp Tissue Inc's consensus rating is "Hold" based on 5 analysts according to Zacks. From those 5 analysts, 1 have buy ratings and 4 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe